Institutional Ownership
Viking Therapeutics Inc
CUSIP 92686J106COMVKTXQ1 2026
13D / 13G Filings
36
Schedule 13D/13G on record
Beneficial Filers
9
Distinct reporting persons
Largest Stake
15.0%
Max % of class reported
Institutional Holders
399
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
36 filings · latest Nov 5, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Nov 5, 2025 | Fmr LLC | 13G/A | 5.1% | 5.77M | SEC |
| 2 | Aug 6, 2025 | Fmr LLC | 13G/A | 8.7% | 9.77M | SEC |
| 3 | May 12, 2025 | Fmr LLC | 13G/A | 10.0% | 11.25M | SEC |
| 4 | Apr 23, 2025 | Blackrock, Inc. | 13G/A | 4.5% | 5.03M | SEC |
| 5 | Feb 4, 2025 | Blackrock, Inc. | 13G | 5.3% | 5.87M | SEC |
| 6 | Nov 14, 2024 | Viking Global Investors LP | 13G/A | 0.6% | 721.9K | SEC |
| 7 | Nov 12, 2024 | Vanguard Group Inc | 13G/A | 9.2% | 10.17M | SEC |
| 8 | Nov 4, 2024 | Vanguard Group Inc | 13G/A | 9.2% | 10.17M | SEC |
| 9 | Oct 18, 2024 | State Street Corp | 13G/A | 4.2% | 4.67M | SEC |
| 10 | Aug 7, 2024 | Blackrock Inc. | 13G/A | 4.9% | 5.46M | SEC |
26 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Viking Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 6.88M | $223.88M |
| 2 | Fmr LLC | 6.02M | $196.05M |
| 3 | Two Sigma Investments, LP | 4.43M | $144.22M |
| 4 | State Street Corp | 4.40M | $143.03M |
| 5 | Raymond James Financial Inc | 2.08M | $113.51M |
| 6 | Morgan Stanley | 3.01M | $98.07M |
| 7 | Geode Capital Management, LLC | 2.08M | $67.77M |
| 8 | American Century Companies Inc | 2.08M | $67.64M |
| 9 | Ameriprise Financial Inc | 1.68M | $54.63M |
| 10 | D. E. Shaw & Co., Inc. | 1.68M | $54.56M |